Given the persistently poor five-year survival rate (<10 %) in metastatic bladder cancer (BLCA) and the limited efficacy of conventional chemotherapy and programmed cell death protein 1 (PD-1) inhibitor monotherapy, there is an urgent need to identify novel immune targets and rational combination strategies. Therefore,...
Wen-Long Wan, Fang Wei, Lu Yang et al.· Biochemical Pharmacology· 0 citations
Pulmonary fibrosis is a frequent complication of abnormal tissue repair following lung injury by many causes. It can be found in various diseases and clinical conditions, such as idiopathic pulmonary fibrosis, cancer-treatment-induced lung injury, and other occupational, environmental, and autoimmune lung diseases. Tho...
Lu Yang, Yu-Ting Huang, An-Dong Liu et al.· Biomedicines· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.